Product Description: Cefuroxime is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].
Applications: COVID-19-immunoregulation
Formula: C16H16N4O8S
Citations: Nat Commun. 2022 Mar 2;13(1):1116./Nat Commun. 2023 Mar 22;14(1):1594./Biomed Res Int. 2018 Jul 2;2018:3579832. /J Chem Inf Model. 2021 Mar 18.
References: [1]Callaghan, et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity in Vitro. Antimicrob Agents Chemother. 1976 Mar;9(3):511-9./[2]D M Ryan, et al. Cefuroxime, a New Cephalosporin Antibiotic: Activity in Vivo. Antimicrob Agents Chemother. 1976 Mar;9(3):520-5.
CAS Number: 55268-75-2
Molecular Weight: 424.39
Compound Purity: 93.0
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Antibiotic;Bacterial;Beta-lactamase
English
Deutsch
